This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Rexing, C. J. Articles by Geck, W. E. Search for Related Content Social Bookmarking                         What's this?

Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Pharmacy Service (119), James A. Haley Veteran's Hospital, Tampa, FL.

Scott D. Troyer

Pharmacy Service (119), James A. Haley Veteran's Hospital, Tampa, FL.

Diane D. Shackelford

Pharmacy Service (119), James A. Haley Veteran's Hospital, Tampa, FL.

Wallace E. Geck

Pharmacy Service (119), James A. Haley Veteran's Hospital, Tampa, FL.

Chronic obstructive pulmonary disease (COPD) is an ever present problem in the United States. Characterized by features of both bronchitis and emphysema, the course is generally slow and progressive. However, acute exacerbations do occur, averaging one to four exacerbations per patient per year. These exacerbations, typically characterized by increasing dyspnea, cough, and sputum production, often require immediate treatment. As single agents, both anticholinergic and ß-adrenergic agents have been proven effective in acute COPD exacerbations, yet their combination may provide little added therapeutic effect over either agent alone. In light of questionable effectiveness and the potential for toxicity, the role of methylxanthines in the management of COPD has been critically evaluated over the past several years. Certain patients may show improvement from the use of corticosteroids and/or antibiotics during an acute exacerbation; however, these patients are not always easily identifiable. Lastly, patients presenting with a PaO₂ < 60 mm Hg will usually benefit from oxygen therapy. This article discusses some of the current views on the efficacy of these various treatments for acute COPD exacerbations.

Journal of Pharmacy Practice, Vol. 5, No. 4, 217-223 (1992)
DOI: 10.1177/089719009200500408


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?